Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF

被引:79
作者
Brès, V
Tagami, H
Péloponèse, JM
Loret, E
Jeang, KT
Nakatani, Y
Emiliani, S
Benkirane, M
Kiernan, RE [1 ]
机构
[1] CNRS, UPR 1142, Inst Genet Humaine, Lab Virol Mol & Transfert Gene, Montpellier, France
[2] CNRS, UPR 9027, Inst Biol Struct & Microbiol, Lab Ingn Syst Macromol, Marseille, France
[3] Inst Cochin, Dept Malad Infect, Paris, France
[4] NIAID, Mol Virol Lab, NIH, Bethesda, MD 20892 USA
[5] Dana Farber Canc Res Ctr, Boston, MA USA
关键词
cyclin T1; differential acetylation; HIV-1; PCAF; Tat;
D O I
10.1093/emboj/cdf669
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The HIV-1 transactivator protein, Tat, is an atypical transcriptional activator that functions through binding, not to DNA, but to a short leader RNA, TAR. Although details of its functional mechanism are still unknown, emerging findings suggest that Tat serves primarily to adapt co-activator complexes such as p300, PCAF and P-TEFb to the HIV-1 long terminal repeat. Hence, an understanding of how Tat interacts with these cofactors is crucial. It has recently been shown that acetylation at a single lysine, residue 50, regulated the association of Tat with PCAF. Here, we report that in the absence of Tat acetylation, PCAF binds to amino acids 20-40 within Tat. Interestingly, acetylation of Tat at Lys28 abrogates Tat-PCAF interaction. Acetylation at Lys50 creates a new site for binding to PCAF and dictates the formation of a ternary complex of Tat-PCAF-P-TEFb. Thus, differential lysine acetylation of Tat coordinates the interactions with its co-activators, cyclin T1 and PCAF. Our results may help in understanding the ordered recruitment of Tat co-activators to the HIV-1 promoter.
引用
收藏
页码:6811 / 6819
页数:9
相关论文
共 54 条
[1]   Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A [J].
Ait-Si-Ali, S ;
Ramirez, S ;
Barre, FX ;
Dkhissi, F ;
Magnaghi-Jaulin, L ;
Girault, JA ;
Robin, P ;
Knibiehler, M ;
Pritchard, LL ;
Ducommun, B ;
Trouche, D ;
Harel-Bellan, A .
NATURE, 1998, 396 (6707) :184-186
[2]  
Barany G., 1979, PEPTIDES A, V2, P1
[3]   Regulated assembly of transcription factors and control of transcription initiation [J].
Beckett, D .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 314 (03) :335-352
[4]   Activation of integrated provirus requires histone acetyltransferase - p300 AND P/CAF are coactivators for HIV-1 Tat [J].
Benkirane, M ;
Chun, RF ;
Xiao, H ;
Ogryzko, VV ;
Howard, BH ;
Nakatani, Y ;
Jeang, KT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) :24898-24905
[5]   TAT TRANS-ACTIVATES THE HUMAN IMMUNODEFICIENCY VIRUS THROUGH A NASCENT RNA TARGET [J].
BERKHOUT, B ;
SILVERMAN, RH ;
JEANG, KT .
CELL, 1989, 59 (02) :273-282
[6]   Recruitment of cyclin T1/P-TEFb to an HIV type I long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription [J].
Bieniasz, PD ;
Grdina, TA ;
Bogerd, HP ;
Cullen, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (14) :7791-7796
[7]   Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication [J].
Brès, V ;
Kiernan, R ;
Emiliani, S ;
Benkirane, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) :22215-22221
[8]   Pituitary adenylyl cyclase-activating peptide: A pivotal modulator of glutamatergic regulation of the suprachiasmatic circadian clock [J].
Chen, D ;
Buchanan, GF ;
Ding, JM ;
Hannibal, J ;
Gillette, MU .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (23) :13468-13473
[9]   A human RNA polymerase II complex containing factors that modify chromatin structure [J].
Cho, H ;
Orphanides, G ;
Sun, XQ ;
Yang, XJ ;
Ogryzko, V ;
Lees, E ;
Nakatani, Y ;
Reinberg, D .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (09) :5355-5363
[10]   Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1 [J].
Chun, RF ;
Jeang, KT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (44) :27888-27894